Private Advisory Group’s Pfizer PFE Stock Holding History

Private Advisory Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.12M	Buy	254,299 +29,858	+13%	+$781K	0.33%	85
2026 Q1	$6.3M	Buy	+224,441	New	+$5.98M	0.41%	70
2022 Q2	–	Sell	-12,282	Closed	-$636K	–	188
2022 Q1	$636K	Sell	12,282 -68,943	-85%	-$3.58M	0.12%	106
2021 Q4	$4.8M	Buy	81,225 +21,664	+36%	+$1.07M	0.9%	29
2021 Q3	$2.56M	Buy	59,561 +8,139	+16%	+$361K	0.63%	42
2021 Q2	$2.01M	Buy	51,422 +17,002	+49%	+$661K	0.51%	45
2021 Q1	$1.25M	Buy	34,420 +13,498	+65%	+$479K	0.36%	56
2020 Q4	$770K	Buy	20,922 +3,635	+21%	+$133K	0.25%	66
2020 Q3	$602K	Buy	17,287 +1,562	+10%	+$54.8K	0.24%	60
2020 Q2	$488K	Buy	+15,725	New	+$534K	0.2%	73
2018 Q2	–	Sell	-64,391	Closed	-$2.17M	–	138
2018 Q1	$2.17M	Buy	+64,391	New	+$2.21M	1.34%	30

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Private Advisory Group's PFE Position: Q2 2026 in Review

Private Advisory Group increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $781K and bringing the position to 254,299 shares worth $6.12M. The position accounts for 0.33% of the portfolio, ranked #85.

Private Advisory Group first reported a position in PFE in Q1 2018 and has held it in 11 quarters since. The position peaked at $6.3M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Private Advisory Group held 254,299 shares of Pfizer worth $6.12M as of Q2 2026.
Private Advisory Group bought 29,858 Pfizer shares in Q2 2026, an estimated $781K.
Pfizer made up 0.33% of Private Advisory Group's portfolio in Q2 2026, its #85 holding.
Private Advisory Group first reported a position in Pfizer in Q1 2018 and has held it in 11 quarters since.
Private Advisory Group's Pfizer position peaked at $6.3M in Q1 2026.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Private Advisory Group's 13F filing for Q2 2026, filed 6 Aug 2026.